Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma

Clinical Cancer Research

Volumn 6, Issue 12, 2000, Pages 4760-4763

  Oh, Min Jeong ^a   Choi, Jin Hyuk ^b   Kim, In Ho ^a   Lee, Yong Ho ^a   Huh, Joon Yong ^a   Park, Yong Kyun ^a   Lee, Kyu Wan ^a   Chough, Soo Yong ^a   Joo, Kap Soon ^a   Ku, Byung Sam ^a   Saw, Ho Suk ^a  

^a Korea University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE OVEREXPRESSION; HUMAN; INVASIVE CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU;

ADULT; AGE FACTORS; AGED; CARCINOMA; CARCINOMA IN SITU; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECURRENCE; UTERINE CERVICAL NEOPLASMS;

EID: 0034485637     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles
2. Requirement for intrinsic protein tyrosine kinase in the immediate and late actions of the EGF receptor
3. EGF receptor
4. Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results
5. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer
6. Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer
7. The relationship of quantitative epidermal growth factor receptor expression in non-small cell lung cancer to long-term survival
8. Detection of epidermal growth factor receptor in the serum of gastric carcinoma patients
9. Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
10. Expression of epidermal growth factor receptor and HER-2/Neu in normal and neoplastic cervix, vulva, and vagina
11. Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement
12. Prognostic value of epidermal growth factor receptor expression in cervical carcinoma
13. Oncogene alterations in carcinomas of the uterine cervix: Overexpression of the epidermal growth factor receptor is associated with poor prognosis
14. Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancer
15. Evaluation of the prognostic significance of cathepsin D, epidermal growth factor receptor, and c-erbB-2 in early cervical squamous cell carcinoma: An immunohistochemical study
16. Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas
17. Expression of epidermal growth factor receptor in carcinoma of the cervix
18. Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium
19. Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an α-difluoromethylornithine chemoprevention trial
20. Patterns of mRNA for epidermal growth factor receptor and keratin B-2 in normal cervical epithelium and in cervical intraepithelial neoplasia
21. Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra-epithelial neoplasia
22. Epidermal growth factor receptor expression and the presence of human papillomavirus in cervical squamous intraepithelial lesions
23. The detection of increased amounts of the extracellular domain of the epidermal growth factor receptor in serum during carcinogenesis in asbestosis patients
24. Cancer and infection: Estimates of the attributable fraction in 1990
25. Staging announcement. FIGO staging of gynecologic cancers: Cervical and vulva
26. Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma
27. Human papillomavirus type 16 E5 protein
28. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor
29. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer
30. Elevated erbB-2 oncoprotein levels in preoperative and follow-up serum samples define an aggressive disease course in patients with breast cancer